Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus-Reference-Cited by-同舟云学术

Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus

Published:2016-07-27 Issue:7 Volume:11 Page:e0159709
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Boyington Jeffrey C.,Joyce M. Gordon,Sastry Mallika,Stewart-Jones Guillaume B. E.,Chen Man,Kong Wing-Pui,Ngwuta Joan O.,Thomas Paul V.,Tsybovsky Yaroslav,Yang Yongping,Zhang Baoshan,Chen Lei,Druz Aliaksandr,Georgiev Ivelin S.,Ko Kiyoon,Zhou Tongqing,Mascola John R.,Graham Barney S.,Kwong Peter D.

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference61 articles.

1. Risk of primary infection and reinfection with respiratory syncytial virus;WP Glezen;Am J Dis Child,1986

2. Respiratory Syncytial Virus-A Comprehensive Review;AT Borchers;Clin Rev Allerg Immu,2013

3. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis;H Nair;Lancet,2010

4. Respiratory syncytial virus infection in elderly and high-risk adults;AR Falsey;New Engl J Med,2005

5. Strategic priorities for respiratory syncytial virus (RSV) vaccine development;LJ Anderson;Vaccine,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bringing immunofocusing into focus;npj Vaccines;2024-01-09

2. A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine;Science Translational Medicine;2022-12-21

3. RSV pre-fusion F protein enhances the G protein antibody and anti-infectious responses;npj Vaccines;2022-12-19

4. A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein;Frontiers in Immunology;2022-08-08

5. Antibodies to combat viral infections: development strategies and progress;Nature Reviews Drug Discovery;2022-06-20